2018, EBITDA, Marketability and Specific Risk

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2018

EBITDA

Marketability

Specific Risk

PARAMETERS UPDATE P5.8

Equidam

FEBRUARY 16, 2024

You can refer to the table at this link to see how they will change for your country specifically. Industry EBITDA multiples used in the VC and DCF with multiple methods Our multiples are based on public market conditions at the beginning of the current year. Data is taken at the global level and aggregated by industry.

EBITDA

EBITDA Specific Risk Banking Marketability

MAEjor Ruling: Delaware Court of Chancery Finds Target Suffers Material Adverse Effect and Acquirer Could Back Out of Transaction

Cooley M&A

OCTOBER 29, 2018

2018-0300-JTL (Del. In April 2017, Fresenius agreed to acquire Akorn, a US-based, Nasdaq-listed specialty manufacturer and marketer of generic prescription and over-the-counter pharmaceutical products, for $35 per share or approximately $4.75 Therefore, the board should have a high degree of confidence in deal certainty.

Compliance

Compliance EBITDA Specific Risk Marketability

Business Valuation Zone

PARAMETERS UPDATE P5.8

MAEjor Ruling: Delaware Court of Chancery Finds Target Suffers Material Adverse Effect and Acquirer Could Back Out of Transaction

Stay Connected